Join
Live feed
·
INSIDERFilingvia Quantisnow
Cue Biopharma Inc. logo

Director Camardo Daniel A. was granted 21,800 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CUE· Cue Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CUE (Cue Biopharma Inc.) and more on Quantisnow.